Morishita R - Search Results

1

Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2/Ets-1 pathway.

Kim MS, Lee CS, Hur J, Cho HJ, Jun SI, Kim TY, Lee SW, Suh JW, Park KW, Lee HY, Kang HJ, Lee DS, Koh GY, Nakagami H, Morishita R, Park YB, Kim HS. Kim MS, et al. Among authors: morishita r. Circulation. 2009 Dec 1;120(22):2240-50. doi: 10.1161/CIRCULATIONAHA.109.856815. Epub 2009 Nov 16. Circulation. 2009. PMID: 19917886

2

Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth.

Aoki M, Morishita R, Matsushita H, Hayashi S, Nakagami H, Yamamoto K, Moriguchi A, Kaneda Y, Higaki J, Ogihara T. Aoki M, et al. Among authors: morishita r. Hypertension. 1999 Aug;34(2):192-200. doi: 10.1161/01.hyp.34.2.192. Hypertension. 1999. PMID: 10454440

3

Transfection of antisense p53 tumor suppressor gene oligodeoxynucleotides into rat carotid artery results in abnormal growth of vascular smooth muscle cells.

Matsushita H, Morishita R, Aoki M, Tomita N, Taniyama Y, Nakagami H, Shimozato T, Higaki J, Kaneda Y, Ogihara T. Matsushita H, et al. Among authors: morishita r. Circulation. 2000 Mar 28;101(12):1447-52. doi: 10.1161/01.cir.101.12.1447. Circulation. 2000. PMID: 10736291

4

Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation.

Matsushita H, Morishita R, Nata T, Aoki M, Nakagami H, Taniyama Y, Yamamoto K, Higaki J, Yasufumi K, Ogihara T. Matsushita H, et al. Among authors: morishita r. Circ Res. 2000 May 12;86(9):974-81. doi: 10.1161/01.res.86.9.974. Circ Res. 2000. PMID: 10807870

5

Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters.

Taniyama Y, Morishita R, Nakagami H, Moriguchi A, Sakonjo H, Shokei-Kim, Matsumoto K, Nakamura T, Higaki J, Ogihara T. Taniyama Y, et al. Among authors: morishita r. Circulation. 2000 Jul 11;102(2):246-52. doi: 10.1161/01.cir.102.2.246. Circulation. 2000. PMID: 10889138

6

Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease.

Yamamoto K, Morishita R, Tomita N, Shimozato T, Nakagami H, Kikuchi A, Aoki M, Higaki J, Kaneda Y, Ogihara T. Yamamoto K, et al. Among authors: morishita r. Circulation. 2000 Sep 12;102(11):1308-14. doi: 10.1161/01.cir.102.11.1308. Circulation. 2000. PMID: 10982548

7

Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells.

Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Matsumoto K, Nakamura T, Kaneda Y, Horiuchi M, Ogihara T. Nakagami H, et al. Among authors: morishita r. Hypertension. 2001 Feb;37(2 Pt 2):581-6. doi: 10.1161/01.hyp.37.2.581. Hypertension. 2001. PMID: 11230338

8

Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.

Taniyama Y, Morishita R, Aoki M, Nakagami H, Yamamoto K, Yamazaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T. Taniyama Y, et al. Among authors: morishita r. Gene Ther. 2001 Feb;8(3):181-9. doi: 10.1038/sj.gt.3301379. Gene Ther. 2001. PMID: 11313789

9

Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes.

Taniyama Y, Morishita R, Hiraoka K, Aoki M, Nakagami H, Yamasaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T. Taniyama Y, et al. Among authors: morishita r. Circulation. 2001 Nov 6;104(19):2344-50. doi: 10.1161/hc4401.098470. Circulation. 2001. PMID: 11696476

10

Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene.

Morishita R, Sakaki M, Yamamoto K, Iguchi S, Aoki M, Yamasaki K, Matsumoto K, Nakamura T, Lawn R, Ogihara T, Kaneda Y. Morishita R, et al. Circulation. 2002 Mar 26;105(12):1491-6. doi: 10.1161/01.cir.0000012146.07240.fd. Circulation. 2002. PMID: 11914260

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

801 results

Search Page

Filters